Cost and access barriers are pushing people to modified use and unapproved versions. About one in 10 American adults took a GLP-1 medication in the past year, and a CDC report published on Nov. 12 says 44% of those users did not take it as prescribed. If you’re one of the millions of Americans currently taking a GLP-1 drug like semaglutide (Ozempic and Wegovy), listen up: The Food and Drug Administration is.